Cancer Treatment Wait Times risking lives
Unacceptable Variations in Cancer Treatment Wait Times Are Putting Lives at Risk!
An exclusive analysis for BBC News by Cancer Research UK has revealed shocking disparities in cancer treatment wait times across England. Patients with head and neck cancers are among those facing the longest delays, with just over half being seen within the target 62 days. In contrast, patients with blood, bone marrow, and skin cancers are far more likely to start treatment on time.
Read the BBC article here.
These aren’t just statistics – lives are at risk. Research shows that a four-week delay to surgery can increase the risk of dying by 6-8% for many cancers. It’s heart breaking to think that while patients wait, their chances of survival decrease.
NHS surgeon and independent peer Lord Darzi has rightly called out these delays as unacceptable. The numbers are staggering:
300,000 cancer patients in England will miss treatment targets over the next five years unless performance improves.
Head and Neck cancer crisis in the UK
While NHS England has made progress, more must be done to address these dangerous waits. Patients with head and neck cancers cannot afford to be left behind.
“At Oracle Head and Neck Cancer UK, we’re tackling this crisis through our RACE initiative—focusing on:
- Research
- Awareness
- Collaboration
- Patient Experience
But we need your help! Join our RACE against time by donating, fundraising, or spreading awareness. Every action makes a difference.
⏳ Every day counts when it comes to cancer – let’s make sure no one has to wait.
💬 Join us in demanding better care! Share this page, spread the word, and explore our website today to see how you can get involved.”
Tamara Kahn, CEO, Oracle Head and Neck Cancer UK
#EndTheWait #CancerCareNow #HeadAndNeckCancer #CancerAwareness #OracleHNC #CancerResearchUK #RACEInitiative
If you’re affected by head and neck cancer or worried about a symptom
Head and neck cancers often go unnoticed, largely because many people are unaware of the signs and symptoms. At Oracle, we urge everyone to take a moment to perform a simple self-check. It could save your life. Visit headneckcheck.com to learn how. If you notice anything unusual, don’t hesitate to consult a healthcare professional.
Additionally, HPV vaccination plays a crucial role in reducing the risk of certain types of head and neck cancers. By protecting yourself, you’re taking an essential step in reducing your risk.
See also patient stories to hear about other people diagnosed with Head and Neck Cancers.
Have you got a symptom, are you being diagnosed, going through treatment, or a friend/carer of someone who is?
Please join our private Facebook Group to get support and advice from fellow patients and carers.
Cancer Care: Why Mental Health Support Must Be Part of Every Cancer Journey
Oracle Head & Neck Cancer UK is proud to support the Daily Express Cancer Care campaign, a powerful series that shines a light on the often unseen emotional toll of cancer – and the urgent need for better psychological support for everyone affected. The campaign published over the past three weeks featured voices from across…
Ground-breaking blood test shows promise for early detection of head & neck and other hard-to-screen cancers
A new large-scale trial has found that the blood-based screening test known as Galleri test can detect more than 50 types of cancer – including cancers of the head and neck, which currently have no routine screening programme – and may significantly boost early diagnosis. The trial showed that, when used alongside existing screening methods,…
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.